Decrease in Antithrombin III Fucosylation by Expressing GDP-fucose Transporter siRNA in Chinese Hamster Ovary Cells (DOI:10.1263/jbb.106.168);Decrease in antithrombin III fucosylation by expressing GDP-fucose transporter siRNA in Chinese hamster ovary cells

Journal of Bioscience and Bioengineering

Volumn 106, Issue 2, 2008, Pages 168-173

  Omasa, Takeshi ^a   Tanaka, Ryo ^a   Doi, Tomohiro ^a   Ando, Masayuki ^a   Kitamoto, Yuka ^a   Honda, Kohsuke ^a   Kishimoto, Michimasa ^b   Ohtake, Hisao ^a  

^a OSAKA UNIVERSITY   (Japan)

^b KYOTO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

antithrombin III; Chinese hamster ovary cells; fucosylation; GDP fucose transporter; small interfering RNA

Indexed keywords

CELLS; CLONING; DNA; RNA;

ANTITHROMBIN III; CHINESE HAMSTER OVARY CELLS; FUCOSYLATION; GDP-FUCOSE TRANSPORTER; SMALL INTERFERING RNA;

CYTOLOGY;

ANTITHROMBIN III; COMPLEMENTARY DNA; GUANOSINE DIPHOSPHATE FUCOSE; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; FUCOSYLATION; GENETIC RECOMBINATION; GENETIC TRANSFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PROTEIN EXPRESSION;

CRICETULUS GRISEUS;

EID: 51549113358     PISSN: 13891723     EISSN: None     Source Type: Journal    
DOI: 10.1263/jbb.106.417     Document Type: Erratum

References (20)

1. Andersen D.C., and Goochee C.F. The effect of cell-culture conditions on the oligosaccharide structures of secreted glycoproteins. Curr. Opin. Biotechnol. 5 (1994) 546-549
2. Kim H.J., and Kim H.-J. Glycosylation variant analysis of recombinant human tissue plasminogen activator produced in urea-cycle-enzyme-expressing Chinese hamster ovary (CHO) cell line. J. Biosci. Bioeng. 102 (2006) 447-451
3. Fujiyama K., Misaki R., Katsura A., Tanaka T., Furukawa A., Omasa T., and Seki T. N-linked glycan structures of a mouse monoclonal antibody produced from tobacco BY2 suspension-cultured cells. J. Biosci. Bioeng. 101 (2006) 212-218
4. Bjork I., Ylinenjarvi K., Olson S.T., Hermentin P., Conradt H.S., and Zettlmeissl G. Decreased affinity of recombinant antithrombin for heparin due to increased glycosylation. Biochem. J. 286 (1992) 793-800
5. Garone L., Edmunds T., Hanson E., Bernasconi R., Huntington J.A., Meagher J.L., Fan B., and Gettins P.G. Antithrombin-heparin affinity reduced by fucosylation of carbohydrate at asparagine 155. Biochemistry 35 (1993) 8881-8889
6. Picard V., Ersdal-Badju E., and Bock S.C. Partial glycosylation of antithrombin III asparagine-135 is caused by the serine in the third position of its N-glycosylation consensus sequence and is responsible for production of the β-antithrombin III isoform with enhanced heparin affinity. Biochemistry 34 (1995) 8433-8440
7. Mori K., Kuni-Kamochi R., Yamane-Ohnuki N., Wakitani M., Yamano K., Imai H., Kanda Y., Niwa R., Iida S., Uchida K., Shitara K., and Satoh M. Engineering Chinese hamster ovary cells to maximize effector function of produced antibodies using FUT8 siRNA. Biotechnol. Bioeng. 88 (2004) 901-908
8. Yamane-Ohnuki N., Kinoshita S., Inoue-Urakubo M., Kusunoki M., Iida S., Nakano R., Wakitani M., Niwa R., Sakurada M., Uchida K., Shitara K., and Satoh M. Establishment of FUT8 knockout Chinese hamster ovary cells: an ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity. Biotechnol. Bioeng. 87 (2004) 614-622
9. Becker D.J., and Lowe J.B. Fucose: biosynthesis and biological function in mammals. Glycobiology 13 (2003) 41R-53R
10. Hirschberg C.B., Robbins P.W., and Abeijon C. Transporters of nucleotide sugars, ATP, and nucleotide sulfate in the endoplasmic reticulum and Golgi apparatus. Annu. Rev. Biochem. 67 (1998) 49-69
11. Ishida N., and Kawakita M. Molecular physiology and pathology of the nucleotide sugar transporter family (SLC35). Pflugers. Arch. 447 (2004) 768-775
12. Lubke T., Marquardt T., Etzioni A., Hartmann E., von Figura K., and Korner C. Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency. Nat. Genet. 28 (2001) 73-76
13. Kanda Y., Imai-Nishiya H., Kuni-Kamochi R., Mori K., Inoue M., Kitajima-Miyama K., Okazaki A., Iida S., Shitara K., and Satoh M. Establishment of a GDP-mannose 4,6-dehydratase (GMD) knockout host cell line: a new strategy for generating completely non-fucosylated recombinant therapeutics. J. Biotechnol. 130 (2007) 300-310
14. Ohya T., Hayashi T., Kiyama E., Nishii H., Miki H., Kobayashi K., Honda K., Omasa T., and Ohtake H. Improved production of recombinant human antithrombin III in Chinese hamster ovary cells by ATF4 overexpression. Biotechnol. Bioeng. 100 (2008) 314-317
15. Omasa T., Higashiyama K., Shioya S., and Suga K. Effect of lactate concentration on hybridoma culture in lactate-controlled fed-batch operation. Biotechnol. Bioeng. 39 (1992) 556-564
16. Hase S. High-performance liquid chromatography of pyridylaminated saccharide. Methods Enzymol. 230 (1994) 225-237
17. Tomiya N., Awaya J., Kurono M., Endo S., Arata Y., and Takahashi N. Analyses of N-linked oligosaccharides using a two-dimensional mapping technique. Anal. Biochem. 171 (1988) 73-90
18. Rabina J., Maki M., Savilahti E.M., Jarvinen N., Penttila L., and Renkonen R. Analysis of nucleotide sugars from cell lysates by ion-pair solid-phase extraction and reversed-phase high-performance liquid chromatography. Glycoconj. J. 18 (2001) 799-805
19. Farquhar M.G., and Palade G.E. The Golgi apparatus (complex)-(1954-1981)-from artifact to center stage. J. Cell Biol. 91 (1981) 77s-103s
20. Baker K.N., Rendall M.H., Hills A.E., Hoare M., Freedman R.B., and James D.C. Metabolic control of recombinant protein N-glycan processing in NS0 and CHO cells. Biotechnol. Bioeng. 73 (2001) 188-202